529
Views
87
CrossRef citations to date
0
Altmetric
Review

Hospitalization in older patients due to adverse drug reactions –the need for a prediction tool

, , , , &
Pages 497-505 | Published online: 02 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Benjamin Skov Kaas-Hansen, Cristina Leal Rodríguez, Davide Placido, Hans-Christian Thorsen-Meyer, Anna Pors Nielsen, Nicolas Dérian, Søren Brunak & Stig Ejdrup Andersen. (2022) Using Machine Learning to Identify Patients at High Risk of Inappropriate Drug Dosing in Periods with Renal Dysfunction. Clinical Epidemiology 14, pages 213-223.
Read now
Yue Tang, Jingui Xie, Aizong Shen, Linlin Liu, Fei Zhai & Changfang Fu. (2022) The impact of prescriber experience and continuity on adverse drug reactions in hospitalized cancer patients. IISE Transactions on Healthcare Systems Engineering 12:2, pages 89-100.
Read now
Tianchi Liu, Christopher Stradford, Ashwin Ambi, Daniel Centeno, Jasmine Roca, Thomas Cattabiani, Thomas J. Drwiega, Clive Li & Christian Traba. (2022) Plasma-initiated graft polymerization of carbon nanoparticles as nano-based drug delivery systems. Biofouling 38:1, pages 13-28.
Read now
Cristina Monteiro, Ana Paula Duarte & Gilberto Alves. (2021) Adverse drug reactions in elderly: a five-year review of spontaneous reports to the Portuguese pharmacovigilance system. Expert Opinion on Drug Safety 20:1, pages 109-118.
Read now
Mainul Haque, Massimo Sartelli, Judy McKimm & Muhamad Abu Bakar. (2018) Health care-associated infections – an overview. Infection and Drug Resistance 11, pages 2321-2333.
Read now
Sule Ajibola Saka, Manimbulu Nlooto & Frasia Oosthuizen. (2018) American Geriatrics Society-Beers Criteria and adverse drug reactions: a comparative cross-sectional study of Nigerian and South African older inpatients. Clinical Interventions in Aging 13, pages 2375-2387.
Read now
Niklas Ekerstad, Kristoffer Bylin & Björn W Karlson. (2017) Early rehospitalizations of frail elderly patients – the role of medications: a clinical, prospective, observational trial. Drug, Healthcare and Patient Safety 9, pages 77-88.
Read now
Joseph Finkelstein, Carol Friedman, George Hripcsak & Manuel Cabrera. (2016) Pharmacogenetic polymorphism as an independent risk factor for frequent hospitalizations in older adults with polypharmacy: a pilot study. Pharmacogenomics and Personalized Medicine 9, pages 107-116.
Read now

Articles from other publishers (79)

Kazi Ishtiak-Ahmed, Ole Köhler-Forsberg, Erik Lykke Mortensen, Andrew A. Nierenberg & Christiane Gasse. (2023) Concurrent use of polypharmacy and potentially inappropriate medications with antidepressants in older adults: A nationwide descriptive study in Denmark during 2015–2019. General Hospital Psychiatry 82, pages 66-74.
Crossref
Rupak Datta, Ling Han, Margaret Doyle, Heather Allore, Tara Sanft, Vincent Quagliarello & Manisha Juthani-Mehta. (2023) Antibiotic therapy is associated with adverse drug events among older adults with advanced cancer: A cohort study. Palliative Medicine, pages 026921632311628.
Crossref
Sheraz Ali, Colin M. Curtain, Gregory M. Peterson & Mohammed S. Salahudeen. (2023) Exploring Australian pharmacists’ perceptions and practices towards reducing the risk of medicines-related harm in aged care residents. Frontiers in Pharmacology 14.
Crossref
Chandrasekhar Nagaraj. 2023. Advances and Challenges in Urine Laboratory Analysis [Working Title]. Advances and Challenges in Urine Laboratory Analysis [Working Title].
David L. Bankes, Hubert Jin, Reginald Williams, Michael S. Awadalla, Joshua Johnson, Jacques Turgeon & Alan Stein. (2023) Implementing pharmacists' medication safety recommendations is associated with reduced health care resource utilization and mortality in high-risk older Americans. Journal of the American Pharmacists Association 63:1, pages 118-124.
Crossref
Mark W. Becker, Deborah A. Kashy, Alyssa Harben, Krishnaa Venkatesan, Andrew Rodriguez, Matt Kebede, Beth Martin, Robert Breslow & Laura Bix. (2023) A novel strategy to optimize critical information on over the counter labels for older adults. Health Science Reports 6:1.
Crossref
Jinjiao Wang, Jenny Y. Shen, Fang Yu, Yeates Conwell, Kobi Nathan, Avantika S. Shah, Sandra F. Simmons, Yue Li, Erika Ramsdale & Thomas V. Caprio. (2022) Medications Associated With Geriatric Syndromes (MAGS) and Hospitalization Risk in Home Health Care Patients. Journal of the American Medical Directors Association 23:10, pages 1627-1633.e3.
Crossref
Min-Gyu Kang, Ju-Yeun Lee, Sung-Il Woo, Kyung-Sook Kim, Jae-Woo Jung, Tae Ho Lim, Ho Joo Yoon, Chan Woong Kim, Hye-Ran Yoon, Hye-Kyung Park & Sang-Heon Kim. (2022) Adverse drug events leading to emergency department visits: A multicenter observational study in Korea. PLOS ONE 17:9, pages e0272743.
Crossref
Mathilde Bories, Guillaume Bouzillé, Marc Cuggia & Pascal Le Corre. (2022) Drug–Drug Interactions with Oral Anticoagulants as Potentially Inappropriate Medications: Prevalence and Outcomes in Elderly Patients in Primary Care and Hospital Settings. Pharmaceutics 14:7, pages 1410.
Crossref
Deirdre T. Criddle, Benjamin Devine, Kevin Murray, Charley A. Budgeon, Frank M. Sanfilippo, Shetaal Gupta, Anthony Davidson, Christopher Etherton-Beer & Rhonda Clifford. (2022) Developing PHarmacie-R: A bedside risk prediction tool with a medicines management focus to identify risk of hospital readmission. Research in Social and Administrative Pharmacy 18:7, pages 3137-3148.
Crossref
Ferda KARTUFAN, Ömer DOĞANAY, Güldem PALAVAN ATA & Çağrı BÜKE. (2022) Knowledge and Awareness of Health Care Associated Infection Control Measures Among Intensive Care Unit Nurses in Hospitals, Turkey. Medical Records.
Crossref
Louis Letinier, Iris Pujade, Perrine Duthoit, Grégoire Evrard, Francesco Salvo, Cédric Gil‐Jardine & Antoine Pariente. (2022) Emergency department admissions induced by drug–drug interactions in the elderly: A cross‐sectional study. Clinical and Translational Science 15:6, pages 1472-1481.
Crossref
Nikki M. F. Noorda, Bastiaan T. G. M. Sallevelt, Wivien L. Langendijk, Toine C. G. Egberts, Eugène P. van Puijenbroek, Ingeborg Wilting & Wilma Knol. (2022) Performance of a trigger tool for detecting adverse drug reactions in patients with polypharmacy acutely admitted to the geriatric ward. European Geriatric Medicine 13:4, pages 837-847.
Crossref
Kathrin Golla, Hanna Mannell, Andreas Benesic, Tobias Dreischulte, Eva Grill & Dorothea Strobach. (2022) Feasibility of the MELD score as a screening tool for pharmacists to identify patients with impaired hepatic function at hospital admission. Journal of Clinical Pharmacy and Therapeutics 47:5, pages 676-684.
Crossref
Erik E. Rabin, Miri Kim, Andreas Mozny, Krislyn Cardoza, April C. Bell, Lijie Zhai, Prashant Bommi, Kristen L. Lauing, Amanda L. King, Terri S. Armstrong, Theresa L. Walunas, Deyu Fang, Ishan Roy, John D. Peipert, Erica Sieg, Xinlei Mi, Christina Amidei, Rimas V. Lukas & Derek A. Wainwright. (2022) A systematic review of pharmacologic treatment efficacy for depression in older patients with cancer. Brain, Behavior, & Immunity - Health 21, pages 100449.
Crossref
H. M. Luttikhuis, L. C. Blomaard, M. A. E. van der Kaaij, K. B. Gombert-Handoko, B. de Groot & S. P. Mooijaart. (2021) Geriatric characteristics and the risk of drug-related hospital admissions in older Emergency Department patients. European Geriatric Medicine 13:2, pages 329-337.
Crossref
Hubert Jin, Sue Yang, David Bankes, Stephanie Finnel, Jacques Turgeon & Alan Stein. (2022) Evaluating the Impact of Medication Risk Mitigation Services in Medically Complex Older Adults. Healthcare 10:3, pages 551.
Crossref
Yu Chen, Shih-Tsung Huang, Tsui-Chuan Hsu, Li-Ning Peng, Fei-Yuan Hsiao & Liang-Kung Chen. (2022) Detecting Suspected Prescribing Cascades by Prescription Sequence Symmetry Analysis of Nationwide Real-World Data. Journal of the American Medical Directors Association 23:3, pages 468-474.e6.
Crossref
Lorène Zerah, Séverine Henrard, Stefanie Thevelin, Martin Feller, Carla Meyer-Massetti, Wilma Knol, Ingeborg Wilting, Denis O’Mahony, Erin Crowley, Olivia Dalleur & Anne Spinewine. (2022) Performance of a trigger tool for detecting drug-related hospital admissions in older people: analysis from the OPERAM trial. Age and Ageing 51:1.
Crossref
Beth A. Martin, Robert M. Breslow, Amanda Sims, Alyssa L. Harben, Laura Bix & Mark W. Becker. (2022) Identifying over-the-counter information to prioritize for the purpose of reducing adverse drug reactions in older adults: A national survey of pharmacists. Journal of the American Pharmacists Association 62:1, pages 167-175.e1.
Crossref
Alyssa L. Harben, Deborah A. Kashy, Shiva Esfahanian, Lanqing Liu, Laura Bix & Mark W. Becker. (2021) Using change detection to objectively evaluate whether novel over-the-counter drug labels can increase attention to critical health information among older adults. Cognitive Research: Principles and Implications 6:1.
Crossref
Peer Oscar Overgaard Stenholt, S. M. Osama Bin Abdullah, Rune Husås Sørensen & Finn Erland Nielsen. (2021) Independent predictors for 90-day readmission of emergency department patients admitted with sepsis: a prospective cohort study. BMC Infectious Diseases 21:1.
Crossref
Fauna Herawati, Ida Bagus Nyoman Maharjana, Tuty Kuswardhani & Astrid Pratidina Susilo. (2020) STOPP-START Medication Review: A Non-Randomized Trial in an Indonesian Tertiary Hospital to Improve Medication Appropriateness and to Reduce the Length of Stay of Older Adults. Hospital Pharmacy 56:6, pages 668-677.
Crossref
Barbara Roux, Julie Berthou-Contreras, Jean-Baptiste Beuscart, Marion Charenton-Blavignac, Jean Doucet, Jean-Pascal Fournier, Blandine de la Gastine, Sophie Gautier, Régis Gonthier, Valérie Gras, Muriel Grau, Pernelle Noize, Elisabeth Polard, Karen Rudelle, Marie-Blanche Valnet-Rabier, Thomas Tannou & Marie-Laure Laroche. (2021) REview of potentially inappropriate MEDIcation pr[e]scribing in Seniors (REMEDI[e]S): French implicit and explicit criteria. European Journal of Clinical Pharmacology 77:11, pages 1713-1724.
Crossref
Daniel Gomes, Eva Rebelo Gomes, Inês Ribeiro-Vaz, Maria Teresa Herdeiro & Fátima Roque. 2021. New Insights into the Future of Pharmacoepidemiology and Drug Safety. New Insights into the Future of Pharmacoepidemiology and Drug Safety.
Maeva Montaleytang, Florian Correard, Charlotte Spiteri, Philippe Boutier, Stéphane Gayet, Stéphane Honore, Patrick Villani & Aurélie Daumas. (2021) Medication reconciliation in the geriatric unit: impact on the maintenance of post-hospitalization prescriptions. International Journal of Clinical Pharmacy 43:5, pages 1183-1190.
Crossref
Juan Lu, Ling Wang, Mohammed Bennamoun, Isaac Ward, Senjian An, Ferdous Sohel, Benjamin J. W. Chow, Girish Dwivedi & Frank M. Sanfilippo. (2021) Machine learning risk prediction model for acute coronary syndrome and death from use of non-steroidal anti-inflammatory drugs in administrative data. Scientific Reports 11:1.
Crossref
Hung-Ling Huang, Meng-Rui Lee, Meng-Hsuan Cheng, Po-Liang Lu, Chun-Kai Huang, Chau-Chyun Sheu, Ping-Chang Lai, Tun-Chieh Chen, Jann-Yuan Wang & Inn-Wen Chong. (2021) Impact of Age on Outcome of Rifapentine-Based Weekly Therapy for Latent Tuberculosis Infection. Clinical Infectious Diseases 73:5, pages e1064-e1071.
Crossref
P.-F. Leclercq, F. Visade, C. Delecluse, E. Floret & A. Lefebvre. (2021) Faisabilité d’une prise en charge médicamenteuse interdisciplinaire ville-hôpital en hôpital de jour gériatrique. Le Pharmacien Hospitalier et Clinicien 56:3, pages 229-235.
Crossref
Jatica Ratanadadas, Thananan Rattanachotphanit & Chulaporn Limwattananon. (2020) Self-administration of medications for chronic diseases and drug-related hospital admissions in elderly patients at a Thai hospital. International Journal of Clinical Pharmacy 43:4, pages 864-871.
Crossref
Malahat Khalili, Bita Mesgarpour, Hamid Sharifi, Asieh Golozar & Ali Akbar Haghdoost. (2021) Estimation of adverse drug reaction reporting in Iran: Correction for underreporting. Pharmacoepidemiology and Drug Safety 30:8, pages 1101-1114.
Crossref
Ben R. Inventor & Olimpia Paun. (2021) Pharmacogenomics in Older Adults: An Integrative Review. Research in Gerontological Nursing 14:4, pages 211-220.
Crossref
Mirjam Kauppila, Janne T. Backman, Mikko Niemi & Outi Lapatto-Reiniluoto. (2020) Incidence, preventability, and causality of adverse drug reactions at a university hospital emergency department. European Journal of Clinical Pharmacology 77:4, pages 643-650.
Crossref
Cristina Monteiro, Beatriz Dias & Maria Vaz-Patto. (2021) Headache as an Adverse Reaction to the Use of Medication in the Elderly: A Pharmacovigilance Study. International Journal of Environmental Research and Public Health 18:5, pages 2674.
Crossref
Nazanin Falconer, Michael Barras, Ahmad Abdel‐Hafez, Sam Radburn & Neil Cottrell. (2020) Development and validation of the Adverse Inpatient Medication Event model (AIME). British Journal of Clinical Pharmacology 87:3, pages 1512-1524.
Crossref
Joanna Hikaka, Rhys Jones, Carmel Hughes, Martin J. Connolly & Nataly Martini. (2021) Ethnic Variations in the Quality Use of Medicines in Older Adults: Māori and Non-Māori in Aotearoa New Zealand. Drugs & Aging 38:3, pages 205-217.
Crossref
Al-Jamei S.Awas A.Al-Sakkaf M.. (2021) Perceptions, Experiences, and Expectations of Hospital Physicians Regarding Pharmacists’ Professional Duties in Yemen. Pharmacophore 12:2, pages 39-45.
Crossref
YE Sari, I Unluoglu, Y Cavusoglu & U Bilge. (2021) Inappropriate drug use rates of geriatric patients attending to a university hospital cardiology policlinic. Nigerian Journal of Clinical Practice 24:11, pages 1719.
Crossref
Pavel Goriacko & Keith T. Veltri. 2021. Geriatric Gastroenterology. Geriatric Gastroenterology 297 339 .
Sara Iasmin Vieira Cunha Lima, Rand Randall Martins, Valdjane Saldanha, Vivian Nogueira Silbiger, Isabelle Cristina Clemente dos Santos, Ivonete Batista de Araújo & Antonio Gouveia Oliveira. (2020) Development and validation of a clinical instrument to predict risk of an adverse drug reactions in hospitalized patients. PLOS ONE 15:12, pages e0243714.
Crossref
Ozan UnluEmily B. Levitan, Evgeniya Reshetnyak, Jerard Kneifati-HayekIvan Diaz, Alexi ArchambaultLigong ChenJoseph T. HanlonMathew S. MaurerMonika M. SaffordMark S. LachsParag Goyal. (2020) Polypharmacy in Older Adults Hospitalized for Heart Failure. Circulation: Heart Failure 13:11.
Crossref
Riitta Turjamaa, Sari Kapanen & Mari Kangasniemi. (2020) How smart medication systems are used to support older people's drug regimens: A systematic literature review. Geriatric Nursing 41:6, pages 677-684.
Crossref
Joanna Hikaka, Carmel Hughes, Rhys Jones, Martin J. Connolly & Nataly Martini. (2020) A pharmacist-led medicines review intervention in community-dwelling Māori older adults– a feasibility study protocol. Research in Social and Administrative Pharmacy 16:9, pages 1264-1271.
Crossref
Edward L. Rogan, Carly A. Ranson, Cynthia S. Valle-Oseguera, Cynthia Lee, Anthony Gumberg, Basirh N. Nagin, Wenwan Cao, Eileen Wang, Catherine Trinh, Kevin Chan, Navpreet Kaur Samra, Emily Win Hou & Rajul A. Patel. (2020) Factors associated with medication-related problems in an ambulatory medicare population and the case for medication therapy management. Research in Social and Administrative Pharmacy 16:6, pages 783-786.
Crossref
Patricia Amoros-Reboredo, Dolors Soy, Marta Hernandez-Hernandez, Sabela Lens & Conxita Mestres. (2020) Anticholinergic Burden and Safety Outcomes in Older Patients with Chronic Hepatitis C: A Retrospective Cohort Study. International Journal of Environmental Research and Public Health 17:11, pages 3776.
Crossref
David Bankes, Hubert Jin, Stephanie Finnel, Veronique Michaud, Calvin Knowlton, Jacques Turgeon & Alan Stein. (2020) Association of a Novel Medication Risk Score with Adverse Drug Events and Other Pertinent Outcomes Among Participants of the Programs of All-Inclusive Care for the Elderly. Pharmacy 8:2, pages 87.
Crossref
Andrea Mencarelli, Merry Gunawan, Kylie Su Mei Yong, Pradeep Bist, Wilson Wei Sheng Tan, Sue Yee Tan, Min Liu, Edwin Kunxiang Huang, Yong Fan, Jerry Kok Yen Chan, Hae Woong Choi, Soman N. Abraham & Qingfeng Chen. (2020) A humanized mouse model to study mast cells mediated cutaneous adverse drug reactions. Journal of Leukocyte Biology 107:5, pages 797-807.
Crossref
Patricia Amoros-Reboredo, Josep Miquel Sotoca, Zoe Mariño, Sergio Rodríguez-Tajes, Anna Pocurull, Dolors Soy, Xavier Forns & Sabela Lens. (2020) Efficacy and safety of direct-acting antivirals in older patients with cirrhosis and high comorbidity index. European Journal of Gastroenterology & Hepatology 32:3, pages 389-394.
Crossref
David L. Bankes, Nishita S. Amin, Chandni Bardolia, Michael S. Awadalla, Calvin H. Knowlton & Kevin T. Bain. (2020) Medication-related problems encountered in the Program of All-Inclusive Care for the Elderly: An observational study. Journal of the American Pharmacists Association 60:2, pages 319-327.
Crossref
Dorothea Strobach, Angelika Poppele, Hanna Mannell, Monika Andraschko, Susanne Schiek & Thilo Bertsche. (2019) Screening for impaired liver function as a risk factor for drug safety at hospital admission of surgical patients. International Journal of Clinical Pharmacy 42:1, pages 124-131.
Crossref
Steven R. EricksonNeil KamdarChung-Hsuen Wu. (2020) Adverse Medication Events Related to Hospitalization in the United States: A Comparison Between Adults With Intellectual and Developmental Disabilities and Those Without. American Journal on Intellectual and Developmental Disabilities 125:1, pages 37-48.
Crossref
Pavel Goriacko & Keith T. Veltri. 2019. Geriatric Gastroenterology. Geriatric Gastroenterology 1 44 .
Ching-Fu Weng, Kun-Pei Lin, Feng-Ping Lu, Jen-Hau Chen, Chiung-Jung Wen, Jui-Hua Peng, Ailun Heather Tseng & Ding-Cheng Chan. (2019) Effects of depression, dementia and delirium on activities of daily living in elderly patients after discharge. BMC Geriatrics 19:1.
Crossref
Joanna Hikaka, Carmel Hughes, Rhys Jones, Martin J. Connolly & Nataly Martini. (2019) A systematic review of pharmacist-led medicines review services in New Zealand – is there equity for Māori older adults?. Research in Social and Administrative Pharmacy 15:12, pages 1383-1394.
Crossref
Andrew Ridge, Kate Macintyre, Alex Kitsos, Linda Murray & Luke Bereznicki. (2019) Assessing risk of adverse drug reactions in the elderly: a feasibility study. International Journal of Clinical Pharmacy 41:6, pages 1483-1490.
Crossref
Young-Mi Ah, Euna Han, Kwanghee Jun, Yun Mi Yu & Ju-Yeun Lee. (2019) Change in sedative burden after dementia onset using difference-in-difference estimations. PLOS ONE 14:8, pages e0220582.
Crossref
Chun Yen Lee & Yi-Ping Phoebe Chen. (2019) Machine learning on adverse drug reactions for pharmacovigilance. Drug Discovery Today 24:7, pages 1332-1343.
Crossref
Shervin Assari, Cheryl Wisseh & Mohsen Bazargan. (2019) Obesity and Polypharmacy among African American Older Adults: Gender as the Moderator and Multimorbidity as the Mediator. International Journal of Environmental Research and Public Health 16:12, pages 2181.
Crossref
Mohsen Bazargan, James Smith, Mohammed Saqib, Hamid Helmi & Shervin Assari. (2019) Associations between Polypharmacy, Self-Rated Health, and Depression in African American Older Adults; Mediators and Moderators. International Journal of Environmental Research and Public Health 16:9, pages 1574.
Crossref
Stefanie Thevelin, Leïla El Mounaouar, Sophie Marien, Benoit Boland, Séverine Henrard & Olivia Dalleur. (2019) Potentially Inappropriate Prescribing and Related Hospital Admissions in Geriatric Patients: A Comparative Analysis between the STOPP and START Criteria Versions 1 and 2. Drugs & Aging 36:5, pages 453-459.
Crossref
Assari & Bazargan. (2019) Race/Ethnicity, Socioeconomic Status, and Polypharmacy among Older Americans. Pharmacy 7:2, pages 41.
Crossref
Shervin Assari, Hamid Helmi & Mohsen Bazargan. (2019) Polypharmacy in African American Adults: A National Epidemiological Study. Pharmacy 7:2, pages 33.
Crossref
Handan Melike Dönertaş, Matías Fuentealba, Linda Partridge & Janet M. Thornton. (2019) Identifying Potential Ageing-Modulating Drugs In Silico. Trends in Endocrinology & Metabolism 30:2, pages 118-131.
Crossref
Shervin Assari & Mohsen Bazargan. (2019) Polypharmacy and Psychological Distress May Be Associated in African American Adults. Pharmacy 7:1, pages 14.
Crossref
AK Mohiuddin. (2018) Pharmacovigilance: Present Scenario and Future Goals. International Journal of Research Foundation of Hospital and Healthcare Administration 6:2, pages 91-98.
Crossref
Su Miin Ong, Yvonne Mei Fong Lim, Sheamini Sivasampu & Ee Ming Khoo. (2018) Variation of polypharmacy in older primary care attenders occurs at prescriber level. BMC Geriatrics 18:1.
Crossref
Stefanie Thevelin, Anne Spinewine, Jean‐Baptiste Beuscart, Benoit Boland, Sophie Marien, Fanny Vaillant, Ingeborg Wilting, Ariel Vondeling, Carmen Floriani, Claudio Schneider, Jacques Donzé, Nicolas Rodondi, Shane Cullinan, Denis O'Mahony & Olivia Dalleur. (2018) Development of a standardized chart review method to identify drug‐related hospital admissions in older people. British Journal of Clinical Pharmacology 84:11, pages 2600-2614.
Crossref
Jessica C. Chun, Susan J. Appel & Steven Simmons. (2018) 2015 Beers criteria medication review in assisted living facilities. Journal of the American Association of Nurse Practitioners 30:11, pages 648-654.
Crossref
Nibu Parameswaran Nair, Leanne Chalmers, Gregory M. Peterson, Bonnie J. Bereznicki, Colin M. Curtain & Luke R. Bereznicki. (2018) Prospective identification versus administrative coding of adverse drug reaction-related hospitalizations in the elderly: A comparative analysis. Pharmacoepidemiology and Drug Safety 27:11, pages 1281-1285.
Crossref
Linda Partridge, Joris Deelen & P. Eline Slagboom. (2018) Facing up to the global challenges of ageing. Nature 561:7721, pages 45-56.
Crossref
O. Ferrández, S. Grau, O. Urbina, S. Mojal, M. Riu & E. Salas. (2018) Validation of a score to identify inpatients at risk of a drug-related problem during a 4-year period. Saudi Pharmaceutical Journal 26:5, pages 703-708.
Crossref
Nazanin Falconer, Michael Barras & Neil Cottrell. (2018) Systematic review of predictive risk models for adverse drug events in hospitalized patients. British Journal of Clinical Pharmacology 84:5, pages 846-864.
Crossref
Mona Kargar, Alireza Ahmadvand & Kheirollah Gholami. (2017) Comment on: “Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals”. Drug Safety 41:3, pages 321-322.
Crossref
Giulia Scondotto, Fanny Pojero, Sebastiano Pollina Addario, Mauro Ferrante, Maurizio Pastorello, Michele Visconti, Salvatore Scondotto & Alessandra Casuccio. (2017) The impact of polypharmacy and drug interactions among the elderly population in Western Sicily, Italy. Aging Clinical and Experimental Research 30:1, pages 81-87.
Crossref
Calvin H. Hirsch, Shyam Maharaj & James A. Bourgeois. 2018. Geriatric Psychiatry. Geriatric Psychiatry 109 134 .
Nibu Parameswaran Nair, Leanne Chalmers, Bonnie J. Bereznicki, Colin M. Curtain & Luke R. Bereznicki. (2017) Repeat Adverse Drug Reaction-Related Hospital Admissions in Elderly Australians: A Retrospective Study at the Royal Hobart Hospital. Drugs & Aging 34:10, pages 777-783.
Crossref
Nibu Parameswaran Nair, Leanne Chalmers, Bonnie J. Bereznicki, Colin Curtain, Gregory M. Peterson, Michael Connolly & Luke R. Bereznicki. (2017) Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals. Drug Safety 40:7, pages 597-606.
Crossref
Gianina Scripcaru, Ceu Mateus & Carla Nunes. (2017) Adverse drug events—Analysis of a decade. A Portuguese case-study, from 2004 to 2013 using hospital database. PLOS ONE 12:6, pages e0178626.
Crossref
Nibu Parameswaran Nair, Leanne Chalmers, Michael Connolly, Bonnie J. Bereznicki, Gregory M. Peterson, Colin Curtain, Ronald L. Castelino & Luke R. Bereznicki. (2016) Prediction of Hospitalization due to Adverse Drug Reactions in Elderly Community-Dwelling Patients (The PADR-EC Score). PLOS ONE 11:10, pages e0165757.
Crossref